0001140361-22-014327.txt : 20220413
0001140361-22-014327.hdr.sgml : 20220413
20220413135632
ACCESSION NUMBER: 0001140361-22-014327
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220408
FILED AS OF DATE: 20220413
DATE AS OF CHANGE: 20220413
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pepose Jay
CENTRAL INDEX KEY: 0001866191
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34079
FILM NUMBER: 22824352
MAIL ADDRESS:
STREET 1: 37000 GRAND RIVER AVE
STREET 2: SUITE 120
CITY: FARMINGTON HILLS
STATE: MI
ZIP: 48335
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ocuphire Pharma, Inc.
CENTRAL INDEX KEY: 0001228627
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113516358
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 37000 GRAND RIVER AVE.
STREET 2: SUITE 120
CITY: FARMINGTON HILLS
STATE: MI
ZIP: 48335
BUSINESS PHONE: 248-681-9815
MAIL ADDRESS:
STREET 1: 37000 GRAND RIVER AVE.
STREET 2: SUITE 120
CITY: FARMINGTON HILLS
STATE: MI
ZIP: 48335
FORMER COMPANY:
FORMER CONFORMED NAME: REXAHN PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20050516
FORMER COMPANY:
FORMER CONFORMED NAME: CORPORATE ROAD SHOW DOT COM INC
DATE OF NAME CHANGE: 20030423
4
1
form4.xml
FORM 4
X0306
4
2022-04-08
0001228627
Ocuphire Pharma, Inc.
OCUP
0001866191
Pepose Jay
C/O OCUPHIRE PHARMA, INC.
37000 GRAND RIVER AVE, SUITE 120
FARMINGTON HILLS
MI
48335
true
Stock Option (right to buy)
2.9
2022-04-08
4
A
0
50000
0
A
2032-04-07
Common Stock
50000
50000
D
The option will vest with respect to 12,500 shares on March 31, 2023, and then with respect to 1,041 shares on the last day of each month from April 2023 through February 2026 and with respect to 1,065 shares at the end of March 2026, subject to the Reporting Person's continuing service through each applicable vesting date.
/s/ Emily J. Johns, by Power of Attorney
2022-04-13